Lysosomal Storage Disease (LSD) Market Report

Global and Region Lysosomal Storage Disease (LSD) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：171
  • REPORT CODE：GMM969655
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Lysosomal Storage Disease (LSD) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Lysosomal Storage Disease (LSD)market, defines the market attractiveness level of Lysosomal Storage Disease (LSD) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Lysosomal Storage Disease (LSD) industry, describes the types of Lysosomal Storage Disease (LSD) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lysosomal Storage Disease (LSD) market and the development prospects and opportunities of Lysosomal Storage Disease (LSD) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lysosomal Storage Disease (LSD) market in Chapter 13.

    By Player:

    • Arena Pharmaceuticals

    • Lexicon Pharmaceuticals

    • Astrazeneca

    • Biomarin Pharmaceutical

    • Astellas Pharma

    • Eli Lilly

    • Actelion Pharmaceuticals

    • Amicus Therapeutics

    • Novo Nordisk

    • Merck

    By Type:

    • Lipid Metabolism Disorder

    • Glycoprotein Metabolism Disorder

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Lysosomal Storage Disease (LSD) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Lysosomal Storage Disease (LSD) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Lysosomal Storage Disease (LSD) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Lysosomal Storage Disease (LSD) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Lysosomal Storage Disease (LSD) Market Analysis and Outlook to 2022

    • 7.1 Global Lysosomal Storage Disease (LSD) Consumption (2017-2022)

    • 7.2 United States Lysosomal Storage Disease (LSD) Consumption (2017-2022)

    • 7.3 Europe Lysosomal Storage Disease (LSD) Consumption (2017-2022)

    • 7.4 China Lysosomal Storage Disease (LSD) Consumption (2017-2022)

    • 7.5 Japan Lysosomal Storage Disease (LSD) Consumption (2017-2022)

    • 7.6 India Lysosomal Storage Disease (LSD) Consumption (2017-2022)

    • 7.7 South Korea Lysosomal Storage Disease (LSD) Consumption (2017-2022)

    8 Region and Country-wise Lysosomal Storage Disease (LSD) Market Analysis and Outlook to 2028

    • 8.1 Global Lysosomal Storage Disease (LSD) Consumption Forecast (2022-2028)

    • 8.2 United States Lysosomal Storage Disease (LSD) Consumption Forecast (2022-2028)

    • 8.3 Europe Lysosomal Storage Disease (LSD) Consumption Forecast (2022-2028)

    • 8.4 China Lysosomal Storage Disease (LSD) Consumption Forecast (2022-2028)

    • 8.5 Japan Lysosomal Storage Disease (LSD) Consumption Forecast (2022-2028)

    • 8.6 India Lysosomal Storage Disease (LSD) Consumption Forecast (2022-2028)

    • 8.7 South Korea Lysosomal Storage Disease (LSD) Consumption Forecast (2022-2028)

    9 Global Lysosomal Storage Disease (LSD) Market Outlook by Types and Applications to 2022

    • 9.1 Global Lysosomal Storage Disease (LSD) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lipid Metabolism Disorder Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Glycoprotein Metabolism Disorder Consumption and Growth Rate (2017-2022)

    • 9.2 Global Lysosomal Storage Disease (LSD) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Lysosomal Storage Disease (LSD) Market Outlook by Types and Applications to 2028

    • 10.1 Global Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Lipid Metabolism Disorder Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Glycoprotein Metabolism Disorder Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Lysosomal Storage Disease (LSD) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Lysosomal Storage Disease (LSD) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Lysosomal Storage Disease (LSD) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Lysosomal Storage Disease (LSD) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Lysosomal Storage Disease (LSD) Market Competitive Analysis

    • 14.1 Arena Pharmaceuticals

      • 14.1.1 Arena Pharmaceuticals Company Details

      • 14.1.2 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Product and Service

    • 14.2 Lexicon Pharmaceuticals

      • 14.2.1 Lexicon Pharmaceuticals Company Details

      • 14.2.2 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Product and Service

    • 14.3 Astrazeneca

      • 14.3.1 Astrazeneca Company Details

      • 14.3.2 Astrazeneca Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Astrazeneca Lysosomal Storage Disease (LSD) Product and Service

    • 14.4 Biomarin Pharmaceutical

      • 14.4.1 Biomarin Pharmaceutical Company Details

      • 14.4.2 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Product and Service

    • 14.5 Astellas Pharma

      • 14.5.1 Astellas Pharma Company Details

      • 14.5.2 Astellas Pharma Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Astellas Pharma Lysosomal Storage Disease (LSD) Product and Service

    • 14.6 Eli Lilly

      • 14.6.1 Eli Lilly Company Details

      • 14.6.2 Eli Lilly Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Eli Lilly Lysosomal Storage Disease (LSD) Product and Service

    • 14.7 Actelion Pharmaceuticals

      • 14.7.1 Actelion Pharmaceuticals Company Details

      • 14.7.2 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Product and Service

    • 14.8 Amicus Therapeutics

      • 14.8.1 Amicus Therapeutics Company Details

      • 14.8.2 Amicus Therapeutics Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Amicus Therapeutics Lysosomal Storage Disease (LSD) Product and Service

    • 14.9 Novo Nordisk

      • 14.9.1 Novo Nordisk Company Details

      • 14.9.2 Novo Nordisk Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novo Nordisk Lysosomal Storage Disease (LSD) Product and Service

    • 14.10 Merck

      • 14.10.1 Merck Company Details

      • 14.10.2 Merck Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck Lysosomal Storage Disease (LSD) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Lysosomal Storage Disease (LSD)

    • Figure Lysosomal Storage Disease (LSD) Picture

    • Table Global Lysosomal Storage Disease (LSD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lysosomal Storage Disease (LSD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lysosomal Storage Disease (LSD) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Lysosomal Storage Disease (LSD) Consumption by Country (2017-2022)

    • Figure United States Lysosomal Storage Disease (LSD) Consumption and Growth Rate (2017-2022)

    • Table Europe Lysosomal Storage Disease (LSD) Consumption and Growth Rate (2017-2022)

    • Figure China Lysosomal Storage Disease (LSD) Consumption and Growth Rate (2017-2022)

    • Figure Japan Lysosomal Storage Disease (LSD) Consumption and Growth Rate (2017-2022)

    • Figure India Lysosomal Storage Disease (LSD) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Lysosomal Storage Disease (LSD) Consumption and Growth Rate (2017-2022)

    • Figure Global Lysosomal Storage Disease (LSD) Consumption Forecast by Country (2022-2028)

    • Figure United States Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Lysosomal Storage Disease (LSD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lipid Metabolism Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Glycoprotein Metabolism Disorder Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Lipid Metabolism Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glycoprotein Metabolism Disorder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Lysosomal Storage Disease (LSD) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Lysosomal Storage Disease (LSD) Export by Region (Top 5 Countries) (2017-2028)

    • Table Arena Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arena Pharmaceuticals Lysosomal Storage Disease (LSD) Product and Service

    • Table Lexicon Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lexicon Pharmaceuticals Lysosomal Storage Disease (LSD) Product and Service

    • Table Astrazeneca (Foundation Year, Company Profile and etc.)

    • Table Astrazeneca Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Lysosomal Storage Disease (LSD) Product and Service

    • Table Biomarin Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biomarin Pharmaceutical Lysosomal Storage Disease (LSD) Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Lysosomal Storage Disease (LSD) Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Lysosomal Storage Disease (LSD) Product and Service

    • Table Actelion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actelion Pharmaceuticals Lysosomal Storage Disease (LSD) Product and Service

    • Table Amicus Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Amicus Therapeutics Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amicus Therapeutics Lysosomal Storage Disease (LSD) Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Lysosomal Storage Disease (LSD) Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Lysosomal Storage Disease (LSD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Lysosomal Storage Disease (LSD) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US